CREATE (Comprehensive Research on Expressed Alleles in Therapeutic Evaluation)
GM063340 (Howard McLeod, PI; Michael Province Project 2 PI & Statistical Genetics Core Director) CREATE is one of the studies of the PharmacoGenetics Research Network. The DSG directs Project 2 and serves as the statistical genetics analysis center for CREATE. Project 2 is using 465 immortalized CEPH cell lines as an ex vivo platform for pharmacogenetic investigation of cancer chemotherapies (e.g. 5-FU, docetoxal). Genome-Wide Linkage Scans, Genome-Wide Association Scans as well as gene expression experiments are being used to localize and identify pharmacodynamic chemotoxicity variants.
Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11809-14. Epub 2004 Jul 28. PMID: 15282376
Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007 Mar;81(3):328-45. Review. PMID: 17339863